Does the Newborn Infant Parasympathetic Evaluation (NIPE) Index Predict Postsurgical Pain in Children
NIPE
1 other identifier
observational
70
1 country
1
Brief Summary
An investigation to find out if Newborn Infant Parasympathetic Evaluation (NIPE) index predicts postsurgical pain in children, since NIPE is thought to may be of guide to the appropriate therapy in a timely and objective manner, thereby improving patient safety, parental satisfaction, and reducing healthcare costs. We think that, validating the utility of NIPE in children under 3 years of age will allow the implementation of a novel pain assessment tool to our current practice of anesthetic care. This will improve the perioperative pain management, in particular for patients who are unable to communicate pain, with the potential to reduce detrimental consequences of postoperative pain. And also determining the relationship between the NIPE scores and validated FLACC scale for post-operative pain and PAED scale during the recovery from anesthesia and also to determine whether NIPE values at extubation correlates with the incidence of moderate and/or severe pain in PACU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2021
CompletedFirst Posted
Study publicly available on registry
June 1, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 3, 2023
May 1, 2023
3 years
May 26, 2021
May 1, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Validation of NIPE as a tool to prevent and assess postoperative pain will improve monitoring of children and potentially their outcome
24 Hours
Interventions
Children between 1 and 3 years old, scheduled for elective adeno-tonsillectomy, tonsillectomy or adenoidectomy and with no neurological or cardiac congenital deficits, no cardiac arrythmias (non-sinus rhythm), no implanted pacemakers, nor with a history of prolonged resuscitation at birth, and chronic therapy with drugs that have known effects on sympathetic and parasympathetic activity, ASA physical status III or higher and parent/guardian refusal will have a NIPE placed on their electrocardiogram, at least 20 minutes before the expected end of the surgery, the NIPE monitor will be connected to the anesthesia monitor at the end of the surgery, when the patient is considered ready to be transferred to the PACU, the NIPE will be disconnected and reconnected to the patient monitor once in PACU. Values will be recorded until the patient meets the discharge criteria from PACU not before 2hours
Eligibility Criteria
Preschool children
You may qualify if:
- Children between 3 and 7 years old, scheduled for elective adeno-tonsillectomy, tonsillectomy or adenoidectomy.
- Only patients whose parents are fluent in French or English will be enrolled
You may not qualify if:
- Patients with neurological or cardiac congenital deficits, with cardiac arrythmias (non-sinus rhythm)
- Implanted pacemakers, with a history of prolonged resuscitation at birth, on chronic therapy with drugs that have known effects on sympathetic and parasympathetic activity (antimuscarinics, beta 2 adrenergic agonists
- Alpha 1-adrenergic antagonists or antiarrhythmic agents,
- Tricyclic antidepressants.
- ASA physical status III or higher and parent/guardian refusal.
- Patients be scheduled for surgery without an appointment at the Montreal Children's Hospital (MCH) Preoperative Clinic
- A surgery appointment within 24 hours of surgery, will not be enrolled into the study.
- As this study will be conducted with only one NIPE monitor, and it will be devoted to the patient for about 1.5 hours, two consecutive patients cannot be enrolled in the study. In this case, the second patient will be considered eligible but excluded, and data will not be collected.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montreal Children's Hospital
Montreal, Quebec, H3C4C9, Canada
Related Publications (1)
Chisling S, Jette E, Engelhardt T, Ingelmo P, Poulin-Harnois C, Garbin M, Wasserman S, Bertolizio G. Does heart rate variability using the Newborn Infant Parasympathetic Evaluation index identify postsurgical pain levels and emergence delirium in toddlers? A prospective observational study. Can J Anaesth. 2024 Aug;71(8):1117-1125. doi: 10.1007/s12630-024-02764-8. Epub 2024 May 8.
PMID: 38720113DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, FRCPC, Associate Professor, Anesthesiologist
Study Record Dates
First Submitted
May 26, 2021
First Posted
June 1, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2024
Study Completion
December 1, 2024
Last Updated
May 3, 2023
Record last verified: 2023-05